LONDON, UK: Kromek Group plc (AIM: KMK) and Analogic Corporation announced on Tuesday that they have joined forces to collaborate on developing next-generation Cadmium Zinc Telluride (CZT) based detector solutions for Photon Counting Computed Tomography (PCCT) applications in the medical imaging and security sectors.
The innovative technology of CZT-based PCCT detectors will enhance spatial resolution, radiation dose reduction, and energy resolution, delivering superior image quality and improving material characterization and quantitative results. This will allow early detection of life-threatening illnesses such as breast cancer and heart disease when used in medical imaging, as well as improved screening for prohibited and dangerous items in real-time with 3D imaging of passenger bags and parcels.
Under the collaboration agreement, Kromek will integrate CZT sensors with Analogic’s detector designs to ensure optimal detection system performance. As the project progresses toward commercialization, Kromek will ensure production capability is available to support Analogic’s PCCT demand.
Analogic has been a global leader in CT detector technology for over 50 years, advancing its product offering of systems and subsystems in both security and medical imaging applications. The company’s PCCT technology is designed to enable new system solutions as well as upgraded options for installed systems.
Kromek’s CEO, Arnab Basu, stated, “At Kromek, we are constantly looking to team up with leading global organizations who match our vision and desire to improve patient outcomes as well as combine our technologies to enhance the safety of our citizens. Analogic has a long track record in doing just this, and we are looking forward to our collaboration to enable Analogic to bring the next generation of CT scanners to the market.”
Analogic CEO Tom Ripp added, “As pioneers in CT imaging and detection technology, we are excited about this collaboration with Kromek to bring the next generation of PCCT detection solutions to market. This project underscores Analogic’s desire to make the world a healthier and safer place for patients and passengers globally.”
This collaboration has the potential to revolutionize medical imaging and security screening, providing enhanced diagnostic capabilities and safety for individuals worldwide.
Kromek enters agreement with Smiths Detection Inc.
Kromek receives Innovate UK funding to advance biological-threat detection solution